Chiropractic + Naturopathic Doctor - May 2019

Brain recode

Victoria Coleman 2019-04-17 23:49:29

Encouraging solutions to clear the fog

Mild cognitive impairment (MCI) is considered a pre-Alzheimer’s disease, characterized by memory problems, impaired thinking, language difficulties, disorientation in time and space, poor judgement and impaired depth perception. Approximately 10-15 per cent of those with MCI will continue on to develop dementia, according to the Alzheimer’s Society.

The tragic social and economic impact need not be highlighted as these diseases have likely touched just about everyone in some manner.

Currently there are no successful pharmaceutical solutions approved for MCI. Clinical trials on two classes of anti-dementia drugs (cholinesterase inhibitors and glutamate receptor antagonist) have been disappointing (Steiner, Bensoussan, Liu, et al, 2018). Dementia has multi-factorial contributing factors and as a result, a one cause, one cure approach is ineffective.

Alzheimer’s has been considered one of the “irreversible” dementia’s but looking at the work of Dr. Dale Bredesen, this is now being re-defined. Dr Bredesen, an expert in the area of neurodegenerative disease, is the founder and CEO of the Buck Institute for Research on Aging, and developed the ReCODE (Reversing Cognitive Decline) protocol. ReCODE addresses cognitive decline from an integrative functional medicine approach and has successfully shown the reversal of cognitive decline in both Alzheimer’s related dementia and MCI (Bredesen, Amos, Canick, et.al. 2016). Dr. Bredesen looks at the disease as physiological imbalances, a synaptoblastic:synaptotrophic imbalance due to metabolic disturbance. Not only has his protocol demonstrated to reverse cognitive decline in areas such as memory, but has actually shown to restore lost hippocampal volume, a key area showing volume loss in diseased brains. (Bredesen, Amos, Canick, et al. 2016) It is also important to understand it is difficult to successfully treat something without understanding the true cause.

There has been a shift in the understanding of the role of amyloid-beta plaques and tau tangles in Alzheimer’s disease. Although these are common traits seen in the brains of these patients, their presence is not necessarily the cause of the disease, but rather the brain’s reaction to neurotoxic effects. In fact, amyloid plaques and tau tangles may be antimicrobial, act as binders of divalent metals, and be a response to a reduction in trophic support. The presence of amyloid beta and tau tangles are therefore more of an effect and not necessarily causal. This would explain why efforts focused only on their reduction has lead to poor outcomes.

Addressing MCI or dementia involves a personalized and programmatic approach (Gustafson, 2015). Identifying and understanding the subtypes of the disease aides in directing where to start in the multiple points of repair addressing 36 metabolic imbalances – referred to as “36 holes in the roof.”

Dr. Bredesen identified three major subtypes of Alzheimer’s disease:

1.Inflammatory (“hot”). Includes causes leading to systematic inflammation including infections, resulting in elevated high-sensitivity C-reactive protein, low albumin:globuin ratio, high cytokine (including interleukin 1 and inter leukin-6)

2.Non-Inflammatory. Atrophic (“cold” loss of trophic support) Reduction in synaptogenesis, reduced support from sex hormones, brain-derived neurotrophic factor, nerve growth factor, insulin, vitamin D, often with increased homocysteine and insulin resistance. There is subtype noted as 1.5: Glycotoxic (“sweet”) Combines both 1 and 2 subtypes.

3.Cortical (“toxic”) An environmental toxin related subtype with chronic inflammation presenting with more general cerebral atrophy. Affects more cognitive functions but not typically memory, seen in younger patients (<65yrs), more often in women, often in APOE negative.

There are additional subtypes including vascular and traumatic have also been cited. (Bredesen, 2015). Although there are differences in these subtypes there are also unifying and overlapping causes.

The first step in this approach is identifying the subtype and then taking a wide approach, involving genetics and lifestyle factors that include diet, sleep, exercise and environmental exposures. Why is this important as a chiropractor? We have the ability to help guide and address key lifestyle areas with patients, and be a conduit for referral to ReCODE doctors, or become certified in the ReCODE protocol.

The ReCODE protocol looks at 36 metabolic imbalances. For optimal outcome all 36 points may be addressed. However, as Dr. Bredesen experienced with one of his first cases, addressing 12 of the 36 points may be enough to get over a threshold (Gustafson, 2015). An important point to remember in this program is the goal is to not only ‘normalize’ metabolic function but to ‘optimize’ metabolic function. An example of this are the optimal values to aim for in these specific areas:

•hs CRP (<1.0mg/L) marker of systemic inflammation

•Fasting insulin l<7mIU/L (18-48 pmol/L) marker of glucose metabolism

•Hemoglobin A1c (<5.5%) marker of glucose metabolism

•Homocysteine (<7umol/L) marker of methylation status

The therapeutic systems look to address the 36 holes identified in the protocol first developed and published in 2014. [Table 1. Therapeutic System 1.0 (Bredesen, 2014)] (Visit canadianchiropractor.ca/brainrecode to view the chart.)

The processes are complex and interconnected, addressing the list below helps to simplify the approach in a step-by-step process for repairing the 36 holes. One step builds on the other and the threshold for improvement is individually determined.

•Reduce inflammation (use biomarkers such as hs-CRP, IL-1, IL-6, TNF alpha) •Normalize glucose and insulin

•Reduce homocysteine

•Restore trophic factors including hormones and vitamin D

•Reduce metal toxicity

•Optimize levels of key nutrients including antioxidants, vitamins and minerals

•Reduce stress

•Improve sleep

•Heal the gut

The best way to demonstrate the protocol is by one of the published case studies in the original 2014 paper (Bredesen, 2014). Summary of Patient:

•Professional male, 69yrs

•11-year history of progressive memory loss. Lost the ability to quickly add numbers/columns in his head

•Multiple testing including PET scan and neuropsychological testing indicating progressing Alzheimer’s disease process was diagnosed

•Labs indicated various markers outside of optimal range including homocysteine, Vit. D, CRP, sex hormones, zinc, copper, thyroid hormones

Therapeutic protocol used:

•Fasting 3 hrs before bedtime and 12 hrs between dinner and breakfast

•Elimination of simple carbohydrates and processed foods

•Increased consumption vegetables and fruits

•Consumed non-farmed fish, occasionally consumed grass fed beef or organic chicken

•Coconut oil, 1 tsp 2x daily

•Slept eight hours nightly

•Exercised strenuously (swam, cycled and ran)

Supplements included:

•Probiotics

•Melatonin 2mg (.5mg 4x daily)

•Bacopa monniera (250mg)

•Ashwagandha (500mg)

•Turmeric (400mg)

•Methycobalamin (1mg)

•Methyltetrahydrofolate (.8mg)

•Pyridoxine 5 phosphate (50mg)

•Citicoline 1,000mg (500mg, 2x daily)

•Vitamin C (1,000mg)

•Vitamin D3 (5,000IU)

•Vitamin E (400IU)

•CoEnzyme Q10 (200mg)

•Zinc picolinate (50mg)

•Alpha lipoid acid (100mg)

•DHA 320mg, EPA 180mg

Results:

After six months on this program the patient, his coworkers, and his wife all noticed marked improvement. He reduced his weight by 10 pounds. Recognition of faces, his memory for work schedules and his ability to quickly add numbers all returned. The rapid and significant cognitive decline in the past few years halted.

Many of these action steps for repair may not be new to integrative doctors. The avoidance of processed foods, eating diet leaning towards ketogenic, reducing inflammation, sleeping, optimizing nutrients, and exercising may seem obvious to some, but the key is employing all of these things to repair the 36 holes and aiming for optimal ranges in stated biomarkers.

DR. VICTORIA COLEMAN is a graduate of the CMCC and a 25-year veteran in health care delivery both clinically and in business development. Dr. Coleman introduced and was President of Douglas Laboratories/Pure Encapsulations Canada for 14 years and served as VP of Clinical Education for Atrium Innovations. Victoria is also a Certified Functional Medicine Practitioner through the Institute of Functional Medicine. She is holds a Master’s degree in Human Nutrition and Functional Medicine.

Visit canadianchiropractor.ca/brainrecode to read this story in its entirety, including

©Annex. View All Articles.

Brain recode
https://magazine.canadianchiropractor.ca/article/Brain+recode/3360948/582057/article.html

Menu
  • Page View
  • Contents View
  • Advertisers
  • Website

Issue List

September/October 2022

July/August 2022

June 2022

March/April 2022

January/February 2022

November/December 2021

September/October 2021

July/August 2021

May/June 2021

March/April 2021

January-February 2021

December 2020

October 2020

September 2020

July/August 2020

June 2020

May 2020

April 2020

February 2020

December 2019

October 2019

September 2019

JulyAugust 2019

June 2019

May 2019

April 2019

February 2019

December 2018

October 2018

September 2018

July/August 2018

June 2018

May 2018

April 2018

February 2018

December 2017

October 2017

September 2017

July 2017

June 2017

May 2017

April 2017

February 2017

December 2016

October 2016

September 2016

July August 2016

June 2016

May 2016

April 2016

February 2016

December 2015

October 2015

September 2015

July August 2015

June 2015

May 2015

April 2015

February 2015

December 2014

October 2014

September 2014

July August 2014

June 2014

May 2014

April 2014

February 2014

December 2013

October 2013

September 2013

July/August 2013

June 2013

May 2013

April 2013

February 2013

December 2012

October 2012

September 2012

July/August 2012

June 2012

May 2012

February 2012

December 2011

October 2011

September 2011

July/August 2011

June 2011

May 2011

April 2011

April 2012

February 2011

December 2010

October 2010

September 2010

July/August 2010

June 2010

May 2010

April 2010

February 2010

December 2009

October 2009

September 2009

July/August 2009

June 2009

May 2009

April 2009

Febuary 2009

December 08

October 08

September 2008

July-Aug 08

June 2008

May 08

April 2008

March 20008

December 2007


Library